• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗中 B 细胞的表现:揭示 B 细胞治疗潜力的奥秘。

B-cell performance in chemotherapy: Unravelling the mystery of B-cell therapeutic potential.

机构信息

Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.

出版信息

Clin Transl Med. 2024 Jul;14(7):e1761. doi: 10.1002/ctm2.1761.

DOI:10.1002/ctm2.1761
PMID:38997802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11245406/
Abstract

BACKGROUND AND MAIN BODY

The anti-tumour and tumour-promoting roles of B cells in the tumour microenvironment (TME) have gained considerable attention in recent years. As essential orchestrators of humoral immunity, B cells potentially play a crucial role in anti-tumour therapies. Chemotherapy, a mainstay in cancer treatment, influences the proliferation and function of diverse B-cell subsets and their crosstalk with the TME. Modulating B-cell function by targeting B cells or their associated cells may enhance chemotherapy efficacy, presenting a promising avenue for future targeted therapy investigations.

CONCLUSION

This review explores the intricate interplay between chemotherapy and B cells, underscoring the pivotal role of B cells in chemotherapy treatment. We summarise promising B-cell-related therapeutic targets, illustrating the immense potential of B cells in anti-tumour therapy. Our work lays a theoretical foundation for harnessing B cells in chemotherapy and combination strategies for cancer treatment.

KEY POINTS

Chemotherapy can inhibit B-cell proliferation and alter subset distributions and functions, including factor secretion, receptor signalling, and costimulation. Chemotherapy can modulate complex B-cell-T-cell interactions with variable effects on anti-tumour immunity. Targeting B-cell surface markers or signalling improves chemotherapy responses, blocks immune evasion and inhibits tumour growth. Critical knowledge gaps remain regarding B-cell interactions in TME, B-cell chemoresistance mechanisms, TLS biology, heterogeneity, spatial distributions, chemotherapy drug selection and B-cell targets that future studies should address.

摘要

背景和正文

近年来,B 细胞在肿瘤微环境(TME)中的抗肿瘤和促肿瘤作用引起了相当大的关注。作为体液免疫的重要协调者,B 细胞在抗肿瘤治疗中可能发挥关键作用。化疗作为癌症治疗的主要手段,影响着各种 B 细胞亚群的增殖和功能及其与 TME 的相互作用。通过靶向 B 细胞或其相关细胞来调节 B 细胞功能,可能会提高化疗疗效,为未来的靶向治疗研究提供有前景的途径。

结论

本综述探讨了化疗与 B 细胞之间的复杂相互作用,强调了 B 细胞在化疗治疗中的关键作用。我们总结了有前途的 B 细胞相关治疗靶点,阐明了 B 细胞在抗肿瘤治疗中的巨大潜力。我们的工作为利用 B 细胞进行化疗和联合治疗癌症策略奠定了理论基础。

关键点

化疗可抑制 B 细胞增殖,并改变亚群分布和功能,包括因子分泌、受体信号转导和共刺激。化疗可调节 B 细胞与 T 细胞的复杂相互作用,对抗肿瘤免疫产生不同的影响。靶向 B 细胞表面标志物或信号转导可提高化疗反应、阻断免疫逃逸和抑制肿瘤生长。目前仍存在一些关键的知识空白,包括 TME 中 B 细胞相互作用、B 细胞化疗耐药机制、生发中心 T 细胞样结构(TLS)生物学、异质性、空间分布、化疗药物选择和 B 细胞靶点,未来的研究应重点关注这些问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c1/11245406/77679dbe2eef/CTM2-14-e1761-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c1/11245406/c4f39ab7748e/CTM2-14-e1761-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c1/11245406/3bdd230284cc/CTM2-14-e1761-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c1/11245406/b83b5b60bf65/CTM2-14-e1761-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c1/11245406/77679dbe2eef/CTM2-14-e1761-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c1/11245406/c4f39ab7748e/CTM2-14-e1761-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c1/11245406/3bdd230284cc/CTM2-14-e1761-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c1/11245406/b83b5b60bf65/CTM2-14-e1761-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c1/11245406/77679dbe2eef/CTM2-14-e1761-g001.jpg

相似文献

1
B-cell performance in chemotherapy: Unravelling the mystery of B-cell therapeutic potential.化疗中 B 细胞的表现:揭示 B 细胞治疗潜力的奥秘。
Clin Transl Med. 2024 Jul;14(7):e1761. doi: 10.1002/ctm2.1761.
2
Tumour Cell Secretome in Chemoresistance and Tumour Recurrence.肿瘤细胞分泌组与化疗耐药及肿瘤复发。
Trends Cancer. 2020 Jun;6(6):489-505. doi: 10.1016/j.trecan.2020.02.020. Epub 2020 Mar 25.
3
Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response.脂质体制剂调节肿瘤微环境和抗肿瘤免疫反应。
Int J Mol Sci. 2018 Sep 26;19(10):2922. doi: 10.3390/ijms19102922.
4
The interactions of paclitaxel with tumour microenvironment.紫杉醇与肿瘤微环境的相互作用。
Int Immunopharmacol. 2022 Apr;105:108555. doi: 10.1016/j.intimp.2022.108555. Epub 2022 Feb 1.
5
Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.改变肿瘤微环境和逆转肿瘤细胞:治疗恶性肿瘤的新策略。
Cell Prolif. 2020 Aug;53(8):e12865. doi: 10.1111/cpr.12865. Epub 2020 Jun 26.
6
Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.通过 TGF-β 阻断 NK 细胞激活但不影响存活,实现人类肿瘤免疫逃逸,从而允许通过治疗恢复抗肿瘤活性。
PLoS One. 2011;6(9):e22842. doi: 10.1371/journal.pone.0022842. Epub 2011 Sep 6.
7
Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities.靶向 B 细胞淋巴瘤的肿瘤微环境:挑战与机遇。
J Hematol Oncol. 2021 Aug 17;14(1):125. doi: 10.1186/s13045-021-01134-x.
8
Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.全面剖析癌症生物学:解析肿瘤微环境,以实现肿瘤学临床的有效癌症治疗。
OMICS. 2020 Apr;24(4):175-179. doi: 10.1089/omi.2020.0019. Epub 2020 Mar 13.
9
Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.肿瘤微环境与癌症和癌症干细胞中的代谢可塑性:耐药性卵巢癌干细胞中代谢和免疫调节特征的观点。
Semin Cancer Biol. 2018 Dec;53:265-281. doi: 10.1016/j.semcancer.2018.10.002. Epub 2018 Oct 11.
10
Beyond the tumour microenvironment.超越肿瘤微环境。
Int J Cancer. 2019 Nov 15;145(10):2611-2618. doi: 10.1002/ijc.32343. Epub 2019 Apr 29.

引用本文的文献

1
Integrative machine learning approach for forecasting lung cancer chemosensitivity: From algorithm to cell line validation.用于预测肺癌化疗敏感性的整合机器学习方法:从算法到细胞系验证
Comput Struct Biotechnol J. 2025 Jul 24;27:3307-3318. doi: 10.1016/j.csbj.2025.07.043. eCollection 2025.
2
Protein Spatial Structure Meets Artificial Intelligence: Revolutionizing Drug Synergy-Antagonism in Precision Medicine.蛋白质空间结构与人工智能相遇:革新精准医学中的药物协同 - 拮抗作用
Adv Sci (Weinh). 2025 Sep;12(33):e07764. doi: 10.1002/advs.202507764. Epub 2025 Aug 7.
3
Integrated multidimensional bioinformatics analysis of the molecular mechanisms of ulcerative colitis-associated colorectal cancer and MMP1 as a potential therapeutic target.

本文引用的文献

1
Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer.化疗免疫治疗在膀胱癌中诱导三级淋巴结构的协同作用。
Br J Cancer. 2024 Apr;130(7):1221-1231. doi: 10.1038/s41416-024-02598-7. Epub 2024 Feb 8.
2
Harnessing natural killer cell effector function against cancer.利用自然杀伤细胞的效应功能对抗癌症。
Immunother Adv. 2023 Dec 21;4(1):ltad031. doi: 10.1093/immadv/ltad031. eCollection 2024.
3
Effect of IL-10-producing B cells in peripheral blood and tumor tissue on gastric cancer.外周血和肿瘤组织中产生 IL-10 的 B 细胞对胃癌的影响。
溃疡性结肠炎相关结直肠癌分子机制的综合多维生物信息学分析及基质金属蛋白酶1作为潜在治疗靶点的研究
Cancer Gene Ther. 2025 Jul 18. doi: 10.1038/s41417-025-00917-5.
4
Natural Killer Cell Immune Checkpoints and Their Therapeutic Targeting in Cancer Treatment.自然杀伤细胞免疫检查点及其在癌症治疗中的靶向治疗
Research (Wash D C). 2025 Jun 3;8:0723. doi: 10.34133/research.0723. eCollection 2025.
5
Tumor-secreted galectin-3 suppresses antitumor response by inducing IL-10 B cells.肿瘤分泌的半乳糖凝集素-3通过诱导白细胞介素-10 B细胞来抑制抗肿瘤反应。
J Immunother Cancer. 2025 May 31;13(5):e011445. doi: 10.1136/jitc-2024-011445.
6
The metabolic dialogue between intratumoural microbes and cancer: implications for immunotherapy.肿瘤内微生物与癌症之间的代谢对话:对免疫治疗的影响
EBioMedicine. 2025 May;115:105708. doi: 10.1016/j.ebiom.2025.105708. Epub 2025 Apr 22.
Cell Commun Signal. 2023 Nov 9;21(1):320. doi: 10.1186/s12964-023-01174-5.
4
Neoadjuvant chemotherapy remodels the tumor immune microenvironment by increasing activated and cytotoxic T cell, decreasing B cells and macrophages in small cell lung cancer.新辅助化疗通过增加小细胞肺癌中活化的细胞毒性T细胞、减少B细胞和巨噬细胞来重塑肿瘤免疫微环境。
J Transl Med. 2023 Sep 21;21(1):645. doi: 10.1186/s12967-023-04526-4.
5
Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy.超越抗 PD-1/PD-L1 时代:BTLA/HVEM 轴作为癌症免疫治疗未来靶点的前景。
Mol Cancer. 2023 Aug 30;22(1):142. doi: 10.1186/s12943-023-01845-4.
6
A chemotherapy response prediction model derived from tumor-promoting B and Tregs and proinflammatory macrophages in HGSOC.一种源自高级别浆液性卵巢癌中促肿瘤B细胞、调节性T细胞和促炎巨噬细胞的化疗反应预测模型。
Front Oncol. 2023 Jul 14;13:1171582. doi: 10.3389/fonc.2023.1171582. eCollection 2023.
7
Memory B cells.记忆B细胞。
Nat Rev Immunol. 2024 Jan;24(1):5-17. doi: 10.1038/s41577-023-00897-3. Epub 2023 Jul 3.
8
Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires.KIR 和 HLA 的等位基因变异调节细胞毒性载荷,并决定 NK 细胞库的功能层次。
Blood Adv. 2023 Aug 22;7(16):4492-4504. doi: 10.1182/bloodadvances.2023009827.
9
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment.吉西他滨联合顺铂治疗后鼻咽癌的肿瘤免疫微环境。
Nat Med. 2023 Jun;29(6):1424-1436. doi: 10.1038/s41591-023-02369-6. Epub 2023 Jun 6.
10
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127 and KLRG1 CD8 T cells.程序性死亡蛋白1(PD-1)阻断通过增加CD127和杀伤细胞凝集素样受体G1(KLRG1)阳性CD8 T细胞增强非小细胞肺癌的新辅助化疗效果。
NPJ Precis Oncol. 2023 May 25;7(1):48. doi: 10.1038/s41698-023-00384-x.